183 related articles for article (PubMed ID: 8294470)
1. Regulation of hepatocytic glycoprotein sialylation and sialyltransferases by peroxisome proliferators.
Fayos BE; Bartles JR
J Biol Chem; 1994 Jan; 269(3):2151-7. PubMed ID: 8294470
[TBL] [Abstract][Full Text] [Related]
2. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins.
Bartles JR; Khuon S; Lin XH; Zhang LQ; Reddy JK; Rao MS; Isoye ST; Nehme CL; Fayos BE
Cancer Res; 1990 Feb; 50(3):669-76. PubMed ID: 2404574
[TBL] [Abstract][Full Text] [Related]
4. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.
Watanabe T; Lalwani ND; Reddy JK
Biochem J; 1985 May; 227(3):767-75. PubMed ID: 4004798
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of adhesion molecules and CD22 ligands.
Hanasaki K; Varki A; Stamenkovic I; Bevilacqua MP
J Biol Chem; 1994 Apr; 269(14):10637-43. PubMed ID: 8144653
[TBL] [Abstract][Full Text] [Related]
6. Postnatal changes in sialylation of glycoproteins in rat liver.
Oda-Tamai S; Kato S; Akamatsu N
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):179-85. PubMed ID: 1741745
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS
Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457
[TBL] [Abstract][Full Text] [Related]
8. Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells.
Perrone CE; Williams GM
Cancer Lett; 1998 Jan; 123(1):27-33. PubMed ID: 9461014
[TBL] [Abstract][Full Text] [Related]
9. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
10. Effects of joint exposures to selected peroxisome proliferators on hepatic acyl-CoA oxidase activity in male B6C3F1 mice.
Ochs JB; Baldwin LA; Leonard DA; Calabrese EJ
Hum Exp Toxicol; 1992 Mar; 11(2):83-8. PubMed ID: 1349224
[TBL] [Abstract][Full Text] [Related]
11. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Li Y; Leung LK; Glauert HP; Spear BT
Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
[TBL] [Abstract][Full Text] [Related]
12. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.
Wilson MW; Leung LK; Hong JT; Glauert HP
Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588
[No Abstract] [Full Text] [Related]
13. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators.
Glauert HP; Hong JT; Leung LK; Wilson MW
Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604
[No Abstract] [Full Text] [Related]
14. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
[TBL] [Abstract][Full Text] [Related]
15. Influence of peroxisome proliferators on phosphoprotein levels in human and rat hepatic-derived cell lines.
Passilly P; Jannin B; Latruffe N
Eur J Biochem; 1995 May; 230(1):316-21. PubMed ID: 7601116
[TBL] [Abstract][Full Text] [Related]
16. Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects.
Rao MS; Thorgeirsson S; Reddy MK; Lalwani ND; Evarts RE; Usman MI; Singh B; Reddy JK
Am J Pathol; 1986 Sep; 124(3):519-27. PubMed ID: 3532814
[TBL] [Abstract][Full Text] [Related]
17. Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver.
Cannon JR; Eacho PI
Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):387-91. PubMed ID: 1747111
[TBL] [Abstract][Full Text] [Related]
18. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
Rao MS; Subbarao V
Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
[TBL] [Abstract][Full Text] [Related]
19. Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators.
Watanabe T; Okawa S; Itoga H; Imanaka T; Suga T
Biochim Biophys Acta; 1992 Apr; 1135(1):84-90. PubMed ID: 1591274
[TBL] [Abstract][Full Text] [Related]
20. Species differences in the hepatic response to a potent peroxisome proliferator.
Makowska JM; Bonner FW; Goldfarb PS; Gibson GG
Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085
[No Abstract] [Full Text] [Related]
[Next] [New Search]
